Angela Perry

Angela Perry possesses extensive experience in the fields of regulatory affairs and clinical research within the cannabis and biotechnology sectors. Currently serving as a Regulatory Affairs Manager at CanniMed Therapeutics Inc. and Aurora Cannabis Inc. since 2015 and 2017, respectively, Angela has previously held roles as a Clinical Trial Scientist and Clinical Trial Lead. Prior experience includes serving as Group Leader for Bioanalytical efforts at Helix BioPharma Corp., where responsibilities involved the development and validation of bioassays for drug products in clinical trials, as well as working as a Laboratory Technician II at Prairie Plant Systems Inc. on molecular detection methods in transgenic plants, and as a Research Technician at Adnavance, contributing to the development of a biosensor. Angela holds a Master of Science in Molecular Biology and two Bachelor of Science degrees in Biochemistry and Animal Sciences from the University of Saskatchewan.